WebNov 17, 2009 · Bioniche Pharma is a global manufacturer of injectable pharmaceutical products serving a variety of niche markets, with expertise in injectable hyaluronic acid products for use in orthopedics, rheumatology, urology, and dermatology. An internal development pipeline and an aggressive acquisition strategy for products fuel the … WebJul 28, 2010 · Bioniche Pharma. Jul 28, 2010, 12:00 ET. LAKE FOREST, Ill., July 28 /PRNewswire/ -- Bioniche Pharma, a leading developer and manufacturer of injectable pharmaceuticals, and Synerx Pharma, LLC ...
About us - bionichepharma.it
WebJul 15, 2010 · Mylan is splashing out $550 million in cash to buy the privately-held Irish firm Bioniche Pharma Holdings in a move that will give the generics major “immediate entry into the North American injectables market”. Bioniche, which is based in Galway, has been owned by US private equity firm RoundTable Health Partners since the beginning by 2006. http://test.pharmabiz.com/news/bioniche-pharma-acquires-duraclon-methadone-hcl-usp-from-xanodyne-53439 high hb low ferritin
Mylan to Acquire Bioniche Pharma Global Injectable …
WebAlchemia Pharma 16 16 produktów; Alpha Pharma 1 1 produkt; AQUILA Pharmacueticals 22 22 produkty; Aurora Remedies 34 34 produkty; B.M Pharmaceuticals 17 17 produktów; Balkan Pharmaceutical 16 16 produktów; Bayer 4 4 produkty; Bio-Peptide 1 1 produkt; Biomedica Foscama Group S.p.A 1 1 produkt; Bioniche Pharma 30 30 produktów; … WebSep 21, 2024 · Manufacture Bm Pharma Cabergoline 1mg tab 50 tabs box. europharmma.com Manufacture Bm Pharma; Cabergoline; 1mg tab; 50 tabs box . Pièces jointes. BM PHARMA CABERBOL 1MG.jpg. 366.6 KB · Affichages: 3 1 Avr. 2024 #1,864 europharmma. ... HALO BIONICHE.jpg. 93.6 KB · Affichages: 3 3 Avr. 2024 WebBioniche Pharma was a leading developer and manufacturer of both branded and generic injectable pharmaceuticals which are either self-manufactured or manufactured for the company on a contract basis. Products were approved for sale in a combination of the U.S., Canadian and European markets. high hbc